# Study to Estimate the Burden of Herpes Zoster and Postherpetic Neuralgia in Spain

> **NCT01521286** · — · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 552 (actual)

## Conditions studied

- Herpes Zoster

## Interventions

- **OTHER:** Data collection

## Key facts

- **NCT ID:** NCT01521286
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2012-03
- **Primary completion:** 2014-11
- **Final completion:** 2015-05
- **Target enrollment:** 552 (ACTUAL)
- **Last updated:** 2015-09-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01521286

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01521286, "Study to Estimate the Burden of Herpes Zoster and Postherpetic Neuralgia in Spain". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01521286. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*